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Abstract
Background: Bovine foamy virus (BFV) encodes the transactivator BTas, which enhances viral gene transcription by
binding to the long terminal repeat promoter and the internal promoter. In this study, we investigated the different
replication capacities of two similar BFV full-length DNA clones, pBS-BFV-Y and pBS-BFV-B.
Results: Here, functional analysis of several chimeric clones revealed a major role for the C-terminal region of the
viral genome in causing this difference. Furthermore, BTas-B, which is located in this C-terminal region, exhibited a
20-fold higher transactivation activity than BTas-Y. Sequence alignment showed that these two sequences differ
only at amino acid 108, with BTas-B containing N108 and BTas-Y containing D108 at this position. Results of mutagenesis
studies demonstrated that residue N108 is important for BTas binding to viral promoters. In addition, the N108D
mutation in pBS-BFV-B reduced the viral replication capacity by about 1.5-fold.
Conclusions: Our results suggest that residue N108 is important for BTas binding to BFV promoters and has a major role
in BFV replication. These findings not only advances our understanding of the transactivation mechanism of BTas, but
they also highlight the importance of certain sequence polymorphisms in modulating the replication capacity of isolated
BFV clones.
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Background
Foamy viruses (FVs) form the only genus in the Spumar-
etrovirinae subfamily of the Retroviridae family and are
widespread in various animals, including simian [1, 2],
bovine [3], equine [4] and feline [5] species. FVs have ex-
tensive cellular tropism and can infect many different
kinds of cells resulting in lytic replication (Cf2Th cells
and BHK-21 cells) or persistence (HEK293T cells and
HeLa cells). However, FVs are nonpathogenic in their
natural hosts or in experimentally infected animals. The
genomic nature, replication strategy, and gene expres-
sion of FVs are different in many aspects from other
retroviruses. The replication of FVs genes is dependent
on two distinct promoters: the 5’ long terminal repeat
(LTR) regulates the expression of three structural genes
(gag, pol and env), and an internal promoter (IP) located
between the env gene and the 3’ LTR also regulates the
expression of two regulatory genes (tas and bet). Tas, a
transcriptional transactivator, is essential for FV replica-
tion. The Tas protein binds directly to a DNA sequence in
the viral LTR promoter and IP to enhance viral gene tran-
scription [6–10]. Nuclear localization of the prototype FV
(PFV) Tas is essential for its transactivation activity and is
regulated by Tas acetylation [11, 12].
Unlike PFV that transmit through both cell-to-cell and
cell-free ways, bovine foamy virus (BFV) infection is
tightly cell-associated. BFV Tas (BTas) contains at least
two functional domains, including the N-terminal DNA-
binding domain (residues 1 to 133) and the C-terminal
activation domain (residues 198 to 249) [10, 13]. BTas
has no classical nuclear localization signal (NLS), yet it
accumulates mainly in the nucleus [14, 15]. Furthermore,
BTas stimulates viral gene transcription through binding to
a region at nucleotide positions −380 to −140 in the BFV
LTR or to a region at nucleotide positions 9205 to 9276 in
the IP [10]. Besides, BTas acetylation and dimerization are
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required for its transactivation function and are crucial for
the replication of BFV [15, 16].
We previously generated the full-length BFV infectious
clone pBS-BFV-Y in 2003 that could produce infectious
BFV and induce cytopathic effects (CPE) in primary fetal
bovine lung (FBL) cells [17]. We subsequently isolated
18 infectious BFV clones including pBS-BFV-B in 2011
and found that the pBS-BFV-Y and pBS-BFV-B viruses
had markedly different replication abilities. In this study,
we identified the BTas protein as one of the determi-
nants of this difference and further showed that a single
amino acid at position 108 in this protein could greatly
modulate BTas transactivation through regulating BTas
binding to the LTR or the IP.
Methods
Reagents
4', 6-Diamidino-2-phenylindole (DAPI) and mouse anti-
tubulin antibody were purchased from Sigma (St. Louis,
MO). Antibodies against the Myc tag and Flag tag were ob-
tained from Santa Cruz Biotechnology (Dallas, USA).
Fluorescein-conjugated anti-rabbit secondary antibodies
were obtained from Jackson ImmunoResearch Laboratories
(West Grove, PA). Mouse anti-Gag [18] and anti-BBet
[19] and rabbit anti-BTas [16] were generated after
immunization with full-length BFV3026 Gag, BBet
and BTas proteins, respectively, purified from bacteria.
These polyclonal antisera were used for immunofluor-
escence assays and Western blotting.
Plasmids
BFV3026 full-length genomic DNA clones, pBS-BFV-Y
(unpublished) and pBS-BFV-B [17], were generated by
our lab. pLTR-Luc and pIP-Luc were constructed as de-
scribed previously [15, 20]. pCMV-AD-BTas (1–133 aa)
was cloned in the pCMV-AD (Stratagene, La Jolla, USA)
vector. pCMV-BTas-Y and pCMV-BTas-B vectors were
constructed by exchanging individual PCR fragments in
the pcDNA3.1(+) vector. pBFV-3'LTR-B-Luc, pBFV-3'LTR-
Y-Luc, pBFV-5'LTR-B-Luc and pBFV-5'LTR-Y-Luc were
constructed by inserting corresponding LTR fragments into
the pGL3basic (Promega) vector. Glutathione S-transferase
(GST)-BTas-Y, GST-BTas-B and GST-BTasD108S were
generated by inserting different btas genes into the
pGEX6P-1 DNA vector. All new constructs were con-
firmed by sequencing.
Cells and viruses
HEK293T, HeLa, Cf2Th, BHK-21 and BFVL (BHK-21-
derived indicator cells containing a luciferase gene under
the control of the BFV LTR) [21] cells were maintained
in Dulbecco’s modified Eagle’s medium (high glucose)
supplemented with 10 % fetal bovine serum (Hyclone,
Victoria, Australia), 50 IU/mL penicillin and 50 μg/mL
streptomycin. Cells were maintained in a humidified at-
mosphere containing 5 % CO2 at 37 °C. HeLa and
HEK293T were transfected by using PEI (Polysciences,
Warrington, USA) or Lipofectamine 2000 (Invitrogen,
Carlsbad, USA) in accordance with the manufacturer’s
instructions. BFV3026 was isolated from peripheral
lymphoid cells by our lab in 1997 [3].
Hirt DNA extraction
Cf2Th cells (5 × 106) infected with BFV3026 for 2 days
were harvested, washed with 10 mL buffer K (20 mM
HEPES, 140 mM KCl, 5 mM MgCl2, 1 mM DL-
Dithiothreitol [DTT]), and lysed with 250 μL buffer K and
7.5 mL 0.5 % Triton X-100 for 10 min at room
temperature. After centrifugation, the pellet was dissolved
in 400 μL TE and 90 mL 5 M NaCl at 4 °C overnight. The
supernatant after centrifugation was extracted with
phenol, chloroform:isoamylalcohol (24:1), and then pre-
cipitated for DNA in ethanol with 0.3 M NaAc at −20 °C
for 1 h. The DNA pellet was then washed with 70 %
ethanol, dissolved in 20 μLTE, and stored at −20 °C.
Western blotting
Cell lysates were separated by 10 % SDS-PAGE (polya-
cryl-amide gel electrophoresis). Proteins were trans-
ferred onto a polyvinylidene difluoride (PVDF)
membrane (Millipore, Billerica, USA). Following incuba-
tion in phosphate-buffered saline (PBS) containing 5 %
non-fat milk for 45 min at room temperature, the mem-
branes were probed with the indicated primary anti-
bodies for 90 min at room temperature or overnight at
4 °C. After incubation with either goat anti-rabbit or
goat anti-mouse secondary antibody, the membranes
were treated with enhanced chemiluminescence reagents
(Millipore, Billerica, USA), and signals were detected by
exposure to X-ray films.
Luciferase reporter assay
HEK293T cells were seeded at a concentration of 2.5 × 105
cells/well. The following day, cells were transfected with
pBS-BFV-B, pBS-BFV-Y or empty vector pBS along with
the luciferase plasmid. pCMV-β-gal was co-transfected as a
control for transfection efficiency. Forty-eight hours after
transfection, cells were harvested in lysis buffer, and
luciferase assays were performed using the luciferase
reporter assay system (Promega, Madison, USA). The
relative luciferase activity was calculated by normaliz-
ing the firefly luciferase activity to the β-galactosidase
(β-Gal) activity. Three independent transfection exper-
iments were performed.
Immunofluorescence assay (IFA)
HeLa cells (3 × 104) were seeded on cover slips in 12-
well plates for 24 h and then transfected with
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pcDNA3.1(+), pcDNA3.1(+)-BTas-Y or pcDNA3.1(+)-
BTas-B. Forty-eight hours later, cells were washed with
PBS twice, followed by fixation in 4 % formaldehyde and
permeabilization in 1 % Triton X-100. Indirect immuno-
fluorescence was carried out with BTas antiserum (1:500
dilution) and a FITC-conjugated goat anti-rabbit second-
ary antibody (1:500 dilution) diluted in antibody solution
(3 % BSA, 1 % Triton X-100 and 0.05 % NaN3 in PBS).
Nuclei of cells were stained with DAPI (0.2 μg/mL).
Fluorescence was observed with an Olympus fluores-
cence microscope.
Crosslinking assay
HEK293T cells were transfected with pcDNA3.1(+)-BTas-
Y, pcDNA3.1(+)-BTas-Y or pcDNA3.1(+). Forty-eight
hours later, cells were washed with ice-cold PBS and lysed
in cross-linking lysis buffer (20 mM Tris-Cl, pH 7.5,
150 mM EDTA, 0.5 mM Na3VO4 and 1 % NP-40)
supplemented with protease inhibitors. The lysates were
sonicated briefly and centrifuged at 15,000 × g for 10 min
at 4 °C. The supernatant was mixed with cross-linking
buffer (0.01 % glutaralde-hyde in 20 mM triethanolamine,
pH 8.2 and 10 mM NaCl) and incubated at room
temperature for 30 min. The cross-linking reaction was
stopped by addition of SDS-PAGE loading buffer, and
proteins were separated by 12 % SDS-PAGE, followed by
immunoblotting with an anti-BTas antibody.
Electrophoretic mobility shift assay (EMSA)
GST fusion proteins were expressed in Escherichia coli
strain BL21 and subsequently purified by glutathione
sepharose 4B beads (GE Healthcare, Uppsala, Sweden).
Protein concentrations were determined by the Bradford
assay. The binding reaction was carried out with 100 ng
purified protein. The BFV LTR probe (613–635) and IP
probe (9243–9264) were synthesized and annealed. All
probes were labeled by digitonin using the DIG Gel Shift
Kit (Roche, Indianapolis, USA). For competition experi-
ments, the following unlabeled competitor oligodeoxynu-
cleotides were added in 20-fold molar excess at the pre-
incubation period: BFV LTR, TRE sense: 5′-ATAGCTA
TTTTAGTAAGTTAGC-3′; BFV IP, TRE sense: 5′-AG
AGCTTAAAAATCAA GGTAAC-3′.
Co-culture assay
BHK-21 cells (1.5 × 105) were seeded in 12-well plates.
Twenty-four hours later, the cells were transfected with
1 μg pBS-BFV DNA. The transfected cells were harvested
48 h post-transfection and then co-cultured with BFVL
reporter cells (8 × 104). After 48 h of co-cultivation, lucif-
erase activity was measured and normalized to the value
of luciferase activity in the uninfected cells.
Results
Two BFV full-length DNA clones produce viruses with
different replication capacities
In order to characterize BFV3026 at the molecular level,
we.amplified the full-length genomic DNA of BFV3026
from the Hirt DNA extracted from infected Cf2Th cells
that can support lytic BFV infection. The amplified virus
DNA fragments were inserted into the pBluescript SK-
(pBS) vector to generate infectious clones [17]. We gener-
ated 18 such clones in 2011 and tested their replication
abilities by transfection into BFVL indicator cells expressing
firefly luciferase under the control of the BFV promoter. As
shown in Fig. 1a, all of the clones were able to activate the
expression of luciferase driven by the BFV promoter.
Compared to the pBS-BFV-Y clone that was generated in
2003 by amplifying viral DNA extracted from BFV-infected
primary FBL cells, these new clones all exhibited higher
levels of transactivation activity. In order to investigate the
genetic basis of this enhancement, one of the highly active
clones #12, hereafter referred to as pBS-BFV-B, was further
investigated.
As shown in Fig. 1b, the pBS-BFV-B DNA clone trans-
activated the BFV LTR ~8-fold more potently than did the
pBS-BFV-Y clone. When viral accessary proteins BTas and
BBet as well as structural protein Gag were examined by
Western blotting, higher levels of these viral proteins were
observed for pBS-BFV-B than pBS-BFV-Y in HEK293T
cells and BFVL cells (Fig. 1c and d). Lastly, these two
infectious clones were transfected into Cf2Th cells, and
formation of syncytium was monitored daily under a
bright-field microscope. Three days post-infection, typical
CPE were observed in cells transfected with pBS-BFV-B
but not with empty vector or pBS-BFV-Y (Fig. 1e). All
together, these data demonstrate that pBS-BFV-B repli-
cated to a greater level compared to pBS-BFV-Y.
C-terminal region of BFV determines different replication
capacities of pBS-BFV-Y and pBS-BFV-B
In order to determine which part of the viral genome is
responsible for the higher replication capacity of pBS-
BFV-B, we divided the viral genome into three segments
using the EcoR I and Nde I restriction enzyme sites,
designated as S1, S2 and S3. Six chimeric clones were
generated as shown in Fig. 2a. To evaluate the replication
abilities of these chimeric clones, they were transfected
into BHK-21 cells that support persistent BFV replication,
followed by co-cultivation with BFVL cells. When the S3
fragment in pBS-BFV-Y was replaced by S3 from pBS-
BFV-B, the chimeric clone Y3 thus generated showed a
higher replication ability than Y, Y1 or Y2 (Fig. 2b). Results
of the pBS-BFV-B mutants showed that substitution of Y-
S3 for the counterpart sequence severely diminished the
replication ability of B clone (Fig. 2b). Levels of the repli-
cation capacities of these BFV clones correlated with levels
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of viral protein expression (Fig. 2c) and the number of
syncytia formed in transfected Cf2Th cells (Fig. 2d).
Notably, the Y3 clone induced more CPE than Y clone,
and the B3 clone lost the ability to generate CPE. To-
gether, these results suggest that the C-terminal region
of the BFV genome (S3 fragment) plays an important
role in viral replication.
Residue N108 is important for the transactivation activity
of BTas
The S3 segment contains the C-terminal region of env,
btas, bbet and 3' LTR (Fig. 2a). In order to further
identify the viral gene responsible for the difference in
replication capacity between pBS-BFV-Y and pBS-BFV-B,
we sequenced their S3 DNA fragments. The sequencing
Fig. 1 Replication capacities of pBS-BFV-B and pBS-BFV-Y. a BFVL cells (8 × 104) were seeded in 12-well plates. After 24 h, 1 μg pBS-BFV DNA together with
50 ng pCMV-β-gal were transfected into BFVL cells, and luciferase activity was measured 48 h later. Relative luciferase activities (Rel. Luc. Act.) are shown.
b HEK293T cells (2.5 × 105) were transfected with 1 μg pBS-BFV-B, pBS-BFV-Y or empty vector pBS together with reporter plasmids, 20 ng pBFV-LTR-Luc
and 10 ng pCMV-β-gal. Forty-eight hours later, the cells were harvested and analyzed using a luciferase activity assay. c Cell lysates from b were harvested
for Western blotting using indicated antibodies. d BFVL cells (8 × 104) were transfected with 1 μg pBS-BFV-B, pBS-BFV-Y or empty vector pBS together with
50 ng pCMV-β-gal. Forty-eight hours later, the cells were harvested and analyzed using a luciferase activity assay. e Cf2Th cells (1.5 × 105) were transfected
with 2 μg pBS, pBS-BFV-Y or pBS-BFV-B. Seventy-two hours later, syncytium was detected in the pBS-BFV-B-transfected Cf2Th cells (white arrows). Luciferase
activities shown are averages from three independent experiments. Error bars indicate standard deviations (SD). *P< 0.05 (unpaired t test), **P< 0.01
(unpaired t test)
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results revealed amino acid changes in the Env, BTas and
BBet proteins (Table 1). We first examined how the
changes affected the transactivation ability of BTas. The
reporter plasmids containing LTRs were transfected to-
gether with the pcDNA3.1(+) vector or BTas expression
plasmids. As shown in Fig. 3a, the basal activity of each
LTR was as low as that of the empty vector pGL3basic in
the absence of BTas, and different BFV LTRs responded
to the transactivation of BTas of different origins at similar
levels. Strikingly, BTas-B activated BFV LTR promoters by
almost 1500-fold, which is ~10-fold higher than did BTas-
Y. This potent activity of BTas-B was also observed with
the IP (Fig. 3b) and in Cf2Th cells (Fig. 3c). In addition,
when the transactivation ability of BTas was examined by
co-transfection with a BTas-deficient infectious clone [19],
expression levels of Gag and BBet were found to be higher
in cells co-transfected with BTas-B than with BTas-Y
(Fig. 3d). In support of its greater transactivation capacity,
BTas-B, but not BTas-Y, helped the BTas-deficient clone
to induce CPE in Cf2Th cells three days post-transfection
(Fig. 3e).
BTas has the DNA binding domain (1–133 aa), activa-
tion domain (198–249 aa), dimerization domain (46–62
aa) and three lysines at positions 66, 109 and 110 that
are acetylated by p300 (Fig. 4a). The sequencing analysis
showed that BTas-Y and BTas-B differed only in the
amino acid at position 108 with D108 for BTas-Y and
N108 for BTas-B (Fig. 4a). To characterize the function
of residue N108, we mutated it to different amino acids
(Fig. 4b). The transactivation ability of BTas-B was de-
creased to the level of that of BTas-Y when N108 was
mutated to aspartic acid (D). The transactivation ability
was also reduced when N108 was mutated to glutamic
acid (E) or leucine (L). No significant difference was ob-
served when N108 was mutated to alanine (A), histidine
(H) or serine (S), with BTas-B-N108S even showing a
slightly higher transactivation activity (Fig. 4b). Similar
results were obtained when experiments were performed
in BFVL or Cf2Th cells (Fig. 4c and d). Together, these
findings demonstrate the importance of residue N108 in
BTas transactivation.
Residue N108 does not affect BTas subcellular localization
or dimerization
Since BTas exerts its transactivation ability in the nu-
cleus, we tested whether N108 has a role in the cellular
distribution of BTas. To this end, plasmids expressing
various BTas proteins were transfected into Hela cells,
and its subcellular localization was evaluated by confocal
microscopy. The results showed that all BTas proteins
were distributed both in the nucleus and the cytoplasm.
BTas-Y showed granular structures in the cytoplasm,
whereas BTas-B and BTas-B-N108S proteins were largely
dispersed in the cytoplasm (Fig. 5a).
Given the critical role of the dimerization domain in
the transactivation function of BTas [15], we also exam-
ined whether residue N108 affects BTas dimerization by
performing a cross-linking assay. The results showed
that both BTas-Y and BTas-B formed dimers after cross-
linking (Fig. 5b), indicating that residue N108 does not
affect dimerization of the BTas protein.
Residue N108 is important for BTas binding to LTR and IP
The DNA binding domain of BTas binds to viral LTR or
IP and is essential for BTas to transactivate viral gene ex-
pression [10]. We therefore hypothesized that the amino
acid at position 108 may be involved in the interaction of
BTas with DNA. To test this hypothesis, EMSA was car-
ried out to evaluate the binding of BTas to BFV LTR and
IP probes as described previously [10]. First, GST-tagged
BTas-Y, BTas-B or BTas-D108S protein was incubated
with BFV LTR DNA probes, followed by electrophoresis
to resolve the protein/DNA complexes. The results
showed direct interaction of BTas-B proteins with LTR
probes (Fig. 5c). These interactions were lost with the
addition of unlabeled LTR (20×) probes, which demon-
strates the specificity of the observed interaction (Fig. 5c).
(See figure on previous page.)
Fig. 2 Activities of chimeric pBS-BFV clones. a The BFV3026 proviral genome is shown at the top. The gray box depicts the BFV3026 proviral genomic
DNA of pBS-BFV-Y, and the white box represents that of pBS-BFV-B. The full-length viral DNA was divided into three segments, S1, S2 and S3, based on
the single restriction enzyme sites of EcoR I and Nde I. The new chimeric clones were generated by exchanging the fragments between pBS-BFV-Y and
pBS-BFV-B plasmids. b-c BHK-21 cells (1.2 × 105) were transfected with 1 μg pBS, pBS-BFV-B, pBS-BFV-Y or different chimeric mutants as indicated. At
48 h post-transfection, cells were harvested and co-cultured with BFVL cells b. Transfected BHK-21 cells were also analyzed by Western blotting to
measure viral protein expression c. d Cf2Th cells (1.5 × 105) were transfected with 2.5 μg pBS, pBS-BFV-B, pBS-BFV-Y or different chimeric mutants as
indicated. Seventy-two hours later, syncytia (white arrows) were recorded using a microscope
Table 1 Sequences of S3 region from BFV-Y and BFV-B
Gene Nuclear acids Amino acids
Position pBS-BFV-Y pBS-BFV-B Position pBS-BFV-Y pBS-BFV-B
env 7965 C G 447 L V
8278 C A 551 A D
8373 A G 583 T A
8547 G A 641 A T
8907 G A 761 V I
btas 9884 G A 108 D N
bbet 10083 G A 72 V I
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In contrast, the BTas-Y protein displayed a much weaker
interaction with LTR probes, compared to BTas-B and
BTas-B-N108S which showed stronger binding to LTR
and exhibited more potent transactivation activities
(Fig. 4b). Similar results were obtained using IP probes.
The purity of these GST-tagged BTas proteins used in
Fig. 3 BTas transactivation of LTR and IP. a HEK293T cells (2.5 × 105) were transfected with 20 ng pGL3basic, BFV-3'LTR-B-Luc, pBFV-3'LTR-Y-Luc,
pBFV-5'LTR-B-Luc or pBFV-5'LTR-Y-Luc together with 100 ng pCDNA3.1+, BTas-B or BTas-Y plasmid as indicated. A luciferase activity assay was performed
48 h post-transfection. b HEK293T cells (2.5 × 105) were transfected with 100 ng BTas, BTas-B or BTas-Y eukaryotic expression plasmid together with 20 ng
pBFV-IP-Luc. Luciferase activity was measured 48 h post-transfection. c Cf2Th cells (8 × 104) were transfected with 200 ng vector, BTas or BTas-B eukaryotic
expression plasmid together with 50 ng pBFV-LTR-Luc or pBFV-IP-Luc. Forty-eight hours later, cells were harvested and analyzed using a luciferase activity
assay. All results shown are averages from three independent experiments. Error bars indicate SD. *P< 0.05 (unpaired t test). d HEK293T cells (2.5 × 105)
were transfected with 200 ng empty vector, BTas-B or BTas-Y eukaryotic expression plasmid together with 800 ng pBS-BFVΔBTas and 50 ng pEGFP-C3.
Forty-eight hours later, cells were harvested for Western blotting using indicated antibodies. e Cf2Th cells (1.5 × 105) were transfected with 200 ng empty
vector, BTas-B or BTas-Y eukaryotic expression plasmid together with 800 ng pBS-BFVΔBTas. Seventy-two hours later, syncytium was detected in pBS-BFV-
B-transfected Cf2Th cells (white arrows)
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EMSA was examined by Coomassie blue staining
(Fig. 5d).
We further examined the interaction between the BTas
binding domain (BD, 1–133 aa) and LTR or IP using the
BFV LTR-Luc or IP-Luc reporter plasmid. The BD of
BTas-Y or BTas-B was fused to the GAL4 activation
domain (AD). After the co-transfection with reporter
plasmids, the binding ability was evaluated by detecting
the expression level of the luciferase reporter. The
results showed that the fusion protein BTas-B (1–133
aa)-GAL4(AD) transactivated LTR or IP ~100 fold greater
than the fusion protein BTas-Y(1–133 aa)-GAL4(AD)
(Fig. 5e). Similar observations were made when experi-
ments were performed in Cf2Th cells (Fig. 5f). Together,
these findings suggest that the residue at position 108 is
important for BTas binding to the BFV LTR or IP.
Mutating N108 impairs BFV replication
In order to determine the importance of BTas N108 in
BFV replication, two BFV mutants, pBS-BFV-Y-D108N
and pBS-BFV-B-N108D, were generated, in which the
amino acid residue at position 108 of BTas was substituted
by N or D, respectively. First, the transactivation activity
of these clones were analyzed in HEK293T cells. The
results showed that the D108N mutation enhanced the
transactivation activity of pBS-BFV-Y, whereas the N108D
mutation impaired pBS-BFV-B transactivation (Fig. 6a).
These clones were then analyzed for their replication
Fig. 4 Residue N108 is important for BTas transactivation. a Schematic representation of the BTas protein. BTas DNA binding domain (1–133 aa)
and activation domain (198–249 aa) on the top are shown in the grey box. The dimerization domain (46–62 aa) is marked with a lighter grey box.
Solid dots represent three lysines at positions 66, 109 and 110 which are also acetylated. Amino acids at position 108 are shown for BTas-Y and BTas-B.
b HEK293T cells were transfected with BTas-Y, BTas-B, mutated BTas-B plasmids or empty vector (100 ng) together with 20 ng pBFV-LTR-Luc, 50 ng
pEGFP-C3 and 10 ng pCMV-β-gal. Luciferase activity was measured 48 h post-transfection. Levels of BTas, GFP and tubulin proteins were measured by
Western blotting. c-d pcDNA3.1(+), BTas-Y, BTas-B and BTas-B mutants were expressed in BFVL c and Cf2Th cells d. Luciferase activity was determined
at 48 h post-transfection
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Fig. 5 (See legend on next page.)
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ability in BHK-21 cells. We observed that BTas protein
expression levels were similar between these clones in
transfected BHK-21 cells (Fig. 6b). Gag expression closely
matched the transactivation results (Fig. 6b). When the
transfected BHK-21 cells were co-cultured with BFVL
indicator cells, we observed that the N108D mutation
impaired the replication capacity of pBS-BFV-B (Fig. 6c).
However, the D108N mutation did not increase the
replication of pBS-BFV-Y (Fig. 6c). In agreement with this
latter observation, the pBS-BFV-B and pBS-BFV-B-
N108D clones, but not pBS-BFV-Y or pBS-BFV-Y-D108N,
caused syncytia in the transfected cells (Fig. 6d). Taken to-
gether, these data suggest that the residue N108 in BTas
modulates the function of BTas as well as BFV replication.
(See figure on previous page.)
Fig. 5 Subcellular localization, dimerization and DNA binding of BTas proteins. a HeLa cells (5 × 104) were transfected with pcDNA3.1(+), BTas-Y,
BTas-B or BTas-B-N108S. Indirect immunofluorescence was performed 48 h post-transfection to visualize subcellular localization of different BTas
proteins (with rabbit anti-BTas antibody at 1:400 dilution and FITC-conjugated goat anti-rabbit secondary antibody at 1:500 dilution). Nuclei were stained
with DAPI (0.2 μg/mL). b HEK293T cells were transfected with BTas-Y, BTas-B or empty vector. Forty-eight hours later, cell lysates were incubated with or
without the cross-linking buffer followed by Western blotting. Positions of BTas monomers (M) and dimers (D) are indicated. c EMSAs were performed
with purified GST-BTas-B, GST-BTas-Y and GST-BTas-B-N108S and GST proteins. DNA probes from BFV-LTR TRE (−368/-346) or BFV-IP TRE (9243–9264) were
labeled with digitonin. d Recombinant proteins GST-BTas-B, GST-BTas-Y, GST-BTas-B-N108S and GST used in EMSA were detected by Coomassie blue
staining. (e) DNA binding ability of BTas was analyzed using a mammalian expression system in HEK293T cells. HEK293T cells (2.5 × 105) were transfected
with 100 ng empty vector, pCMV-AD-BTas-B (1–133 aa) or pCMV-AD-BTas-Y (1–133 aa) together with 20 ng pBFV-LTR-Luc or pBFV-IP-Luc. Forty-eight
hours later, luciferase activities were measured as described in Materials and Methods. f Experiments in e were carried out in Cf2Th cells. All results shown
are the average from three independent experiments. Error bars indicate SD. *P< 0.05 (unpaired t test), **P< 0.01 (unpaired t test)
Fig. 6 Residue N108 in BTas is important for BFV replication. a HEK293T cells (2.5 × 105) were transfected with 1 μg pBS, pBS-BFV-Y, pBS-BFV-B, pBS-
BFV-Y-D108N or pBS-BFV-B-N108D, together with pBFV-LTR-Luc and pCMV-β-gal. Forty-eight hours later, the cells were collected and analyzed using a
luciferase activity assay. b-c BHK-21 cells (1.2 × 105) were transfected with 1 μg pBS, pBS-BFV-Y, pBS-BFV-B, pBS-BFV-Y-D108N or pBS-BFV-B-N108D. At
48 h post-transfection, cells were harvested for Western blotting to measure viral protein expression b. Cells were also co-cultured with BFVL cells.
Luciferase was measured 48 h post-infection c. d Cf2Th cells (1.5 × 105) were transfected with 2.5 μg pBS, pBS-BFV-Y, pBS-BFV-B, pBS-BFV-Y-D108N or
pBS-BFV-B-N108D. Seventy-two hours later, syncytia formation (white arrows) was analyzed by microscopy. All results shown are the average from three
independent experiments. Error bars indicate SD. *P < 0.05 (unpaired t test), **P < 0.01 (unpaired t test)
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The results also suggest that changes in other viral genes
or regions between pBS-BFV-B and pBS-BFV-Y also
account for their different replication capacities.
Discussion
BTas is a key regulator for BFV gene expression. BTas
harbors a DNA binding domain and a transactivation do-
main, both of which are required for the transactivation
function [10, 22]. In this study, the different replication
abilities of two BFV3026 full-length clones were investi-
gated. The data showed that these two viral clones differ
in their BTas proteins at amino acid position 108 and that
this amino acid is important for the direct interaction of
BTas to LTR or IP, consequently determining the transac-
tivation ability of BTas as well as viral replication.
Our lab isolated the BFV3026 strain from bovine per-
ipheral blood lymphocytes in 1996 [3] and had passaged
this virus in primary FBL cells. In 2002, we first cloned
the btas gene of BFV3026 from the Hirt DNA extracted
from infected FBL cells. The BTas protein encoded by
this clone contains the D residue at position 108. The
full-length clone pBS-BFV-Y was generated in 2003 by
PCR also using DNA that was extracted from infected
FBL cells. In this full-length clone, the encoded BTas
protein also has D108. Since FBL cells are primary cells
and must be discarded after several passages, we have
been passaging the BFV3026 virus in the Cf2Th cell line
since 2008. We generated 18 full-length BFV DNA
clones using Hirt DNA extracted from infected Cf2Th
cells in 2011, one of which was pBS-BFV-B. In addition
to pBS-BFV-B, we have also sequenced the btas gene in
five clones with low replication capacities and two clones
with high replication abilities. In all of these seven
clones, BTas carries the residue N at position 108. We
suspected that the different residues at position 108 in
BTas had resulted from the use of different cell types for
replicating BFV. Thus, single genome amplification
(SGA) was performed to determine the btas sequences
from the BFV3026 viruses that were cultivated in FBL
cells and had been stored at different times from 2003 to
2008. Among the 25 sequences obtained, only one BTas
has D108, while the others contain N108. We also exam-
ined the btas genes of BFV strains from other locations
and found that they bear N108 [23]. These findings indi-
cate that N108 is a highly conserved residue of BTas,
and the 108D mutation is likely a defective variant in the
BFV3026 virus population. Considering D to N mutation
of the amino acids at 108 site of BTas was induced by G
to A mutation, it might be a reason that after long term
cultivation, the viral genomes were edited by apolipopro-
tein B mRNA editing enzyme 3 (APOBOEC3), which
could induce G to A shift.
Residue N108 is located in the DNA binding domain
of the BTas protein. Results of the mutagenesis analysis
support a role for N108 in the binding of BTas to viral
promoters and therefore the transactivation activity of
BTas. Further studies showed that N108D neither seques-
tered BTas in the cytoplasm or the nucleus, nor impaired
the dimerization of BTas (Figs. 5 and 6). Previous studies
have shown that lysines at positions 66, 109 and 110 were
important for BTas binding to DNA. The K110R mutant
was found to have lost binding to the BFV promoter and
the transactivation ability when the 108 position was
occupied by D [16]. Interestingly, the D108N substitution
increased the transactivation activity of K110R by ~20-fold
(data not shown). The negative charge of D or E at
position 108 possibly deters the binding of BTas to the
negatively charged DNA, in contrast to the positively
charged patch formed by K66/109/110 that stabilizes BTas
binding to DNA. We cannot rule out the possibility that
N108 facilitates the adoption of an active conformation of
BTas. Structural studies are expected to provide definitive
answers to these possibilities.
N108 is important for the transactivation ability of BTas
and protein expression of BFV, including Gag, BBet and
BTas. However, the D108N mutation in the context of
BFV-Y did not increase the replication ability of this
replication-deficient clone (Fig. 6c and d). In addition, the
BFV clones with lower replication capacities shown in
Fig. 1a also harbor N108 in BTas, suggesting the existence
of additional viral determinants for BFV replication. These
viral replication determinants may be located in other viral
genes or regions in the S3 fragment or in the S1 or S2
segments, since substitution of pBS-BFV-Y S1 and S2 also
diminished the replication capacity of pBS-BFV-B (Fig. 2b).
Further studies are warranted to identify these viral deter-
minants for BFV replication.
Conclusions
In summary, we have discovered the important role of
amino acid N108 in the transactivation activity of BTas
and the replication of BFV3026. This function of N108
is attributed to its modulation of the binding of BTas to
viral promoter DNA.
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